1. Home
  2. LBRDP vs CGEN Comparison

LBRDP vs CGEN Comparison

Compare LBRDP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

LBRDP

Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

N/A

Current Price

$24.40

Market Cap

0.0

ML Signal

N/A

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.53

Market Cap

125.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDP
CGEN
Founded
N/A
1993
Country
United States
Israel
Employees
1900
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
125.3M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
LBRDP
CGEN
Price
$24.40
$1.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
295.7K
Earning Date
N/A
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$231.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.13
52 Week High
N/A
$2.66

Technical Indicators

Market Signals
Indicator
LBRDP
CGEN
Relative Strength Index (RSI) 47.69 43.59
Support Level $24.29 $1.47
Resistance Level $24.67 $1.72
Average True Range (ATR) 0.23 0.09
MACD 0.00 0.01
Stochastic Oscillator 40.68 24.01

Price Performance

Historical Comparison
LBRDP
CGEN

About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: